The results showed that uPA was significantly overexpressed in prostate cancer compared to peritumoral tissues (Figures 1A, B, Supplementary Figure 1A), suggesting that uPA may be an effective therapeutic target for prostate cancer. The gene discussed is PLAU; the disease is prostate carcinoma.